Cipla Limited Cipla Limited

Cipla Limited

CIPLA

Classificação em ações #1809
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Preço da ação
$14.61
Última sincronização: 2026-10-19
Valor de mercado
$11.81B
Variação (1 dia)
-0.11%
Variação (1 ano)
-21.65%
País
IN
Negociar Cipla Limited (CIPLA)

Categoria

Healthcare
Histórico de desdobramentos de ações de Cipla Limited (CIPLA)
As ações Cipla Limited (símbolo: CIPLA) passaram por um total de 4 desdobramentos.
O desdobramento mais recente ocorreu em Apr 24, 2006.
Uma ação CIPLA comprada antes de Oct 18, 1999 equivaleria hoje a 112.5 ações CIPLA.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
2006-04-24 5:2 x2.5 x112.5
2004-05-11 5:1 x5 x45
1999-10-21 3:1 x3 x9
1999-10-18 3:1 x3 x3
Desdobramentos de ações de empresas semelhantes ou concorrentes